跳至主要内容
临床试验/ISRCTN11916601
ISRCTN11916601已完成Unknown

A prospective, single-centre pilot trial to evaluate the feasibility and safety of ultrasound-guided direct portal vein pressure gradient measurement in patients with non-neoplastic hepatic disorders

Kantonsspital St. Gallen0 个研究点目标入组 18 人开始时间: 2023年11月21日最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patient planned to undergo transient elastography and percutaneous liver biopsy via the right lobe of the liver in frame of standard diagnostics for non-neoplastic hepatic disorders regardless of the stage of fibrosis
  • 2. Patient available for planned follow-up for at least 1 month
  • 3. Male or female aged =18 years
  • 4. Must be willing and able to give written informed consent to participate in the study and agree to comply with the study protocol prior to initiation of any study-mandated procedure and study intervention

排除标准

  • 1. Patient with primary neoplastic hepatic disorders and/or liver metastasis
  • 2. Patient planned to undergo biopsy of a focal liver lesion or biopsy via the left lobe of the liver
  • 3. Patient on any anticoagulation therapy at the time point of liver biopsy that cannot be stopped prior to actual conduct of liver biopsy
  • 4. Patient having coagulation disorder defined as INR =1.5 and thrombocytes =70 G/l
  • 5. Patient with Body Mass Index (BMI) =35
  • 6. Patient with ascites
  • 7. Patient with known allergies to ultrasound contrast agent SonoVue®
  • 8. Patient with known right-to-left shunts, severe pulmonary hypertension (pulmonary arterial pressure > 90 mmHg), uncontrolled systemic hypertension or Respiratory Distress Syndrome (ARDS)
  • 9. Patient on dobutamine therapy
  • 10. Patient allergic to porcine collagen
  • 11. Participation in another study with an investigational drug/device within the 30 days preceding and during the present study
  • 12. Previous enrolment into the current study
  • 13. Enrolment of the study investigator, his/her family members, employees and other dependent persons
  • 14. If female and of childbearing potential: known pregnancy or a positive urine pregnancy test (confirmed by a positive serum pregnancy test), or lactating
  • Note: female patients who are surgically sterilized/hysterectomized or post-menopausal for longer than 2 years are not considered as being of child-bearing potential

研究者

相似试验

已完成
不适用
A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinomacholangiocarcinoma
JPRN-UMIN000025915Okayama University Hospital20
进行中(未招募)
1 期
A pilot study to assess the efficacy and safety of CBD oral solution in addition to standard treatment for pediatric subjects with Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy (DEE)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disorders
EUCTR2019-001633-14-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA20
已完成
不适用
A single-center, open pilot trial to investigate the performance of the modified intravascular microdialysis probe MicroEye® in healthy subjectsHealthy Subjects
DRKS00015049A. Menarini Diagnostics S.r.l.20
尚未招募
不适用
Prospectiv, single-center trial to evaluate the rate of of hypoxaemia and hypotension in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) with sedation.K83.0K76.9Liver disease, unspecifiedCholangitis
DRKS00005201Interdisziplinäres Endoskopie ZentrumUniklinikum Heidelberg200
进行中(未招募)
不适用
A pilot single-centre randomised controlled trial of recombinant human erythropoietin versus placebo in primary progressive multiple sclerosis.Primary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10063401Term: Primary progressive multiple sclerosis
EUCTR2008-005125-11-GBWalton Centre for Neurology and Neurosurgery